Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04141878 · ClinicalTrials.gov registry record · NA

Dementia and Diabetes Prevention Program

A NA study of Diabetes and Dementia, sponsored by University of California, Davis.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT04141878: Recruiting NA study of Diabetes and Dementia, sponsored by University of California, Davis.

NCT04141878 is a NA study of Diabetes and Dementia that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 400 participants, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04141878, a NA study of Diabetes and Dementia, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

This is a multicenter, randomized 2-arm clinical trial of two lifestyle interventions varying in intensity and format, in 400 older African American and non-Hispanic whites at increased risk of cognitive decline and dementia in the East San Francisco Bay Area. The trial will include two lifestyle interventions that differ in intensity and format: 1. Aerobic Exercise (AEx) Intervention that involves aerobic activities with in-class walking workouts and tutorials and carried out at the East Oakland Sports Center (EOSC) and Tice Creek Fitness Center (TICE). 2. Dietary counseling to support adherence to the Mediterranean-Diet Approaches to Stop Hypertension (DASH) Intervention for Neurodegenerative Delay (MIND) diet to encourage increased consumption of berries, green leafy and other vegetables, whole grains, nuts, fish, poultry, beans and olive oil, and to reduce consumption of fried/fast foods, red meat, whole fat cheese, sweets, butter and trans-fat margarines.

Primary Outcome

Cognitive Performance

Conditions Studied

Interventions

  • BEHAVIORAL Aerobic Exercise
  • BEHAVIORAL Diet Skills

Study Locations (1)

California

  • University of California, Davis Alzheimer's Disease Center - Walnut Creek

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2021-05-26
Est. Completion 2026-06-27
Phase NA
University of California, Davis

657 total trials

What NCT04141878 shows while recruiting

NCT04141878 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (87% lower).

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Aerobic Exercise is the first listed.

NCT04141878 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04141878 about?

NCT04141878 is a clinical study titled "Dementia and Diabetes Prevention Program". This is a multicenter, randomized 2-arm clinical trial of two lifestyle interventions varying in intensity and format, in 400 older African American and non-Hispanic whites at increased risk of cognitive decline and dementia in the East San Francisco Bay Area. The trial will include two lifestyle in...

What is the current status of trial NCT04141878?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2021-05-26. Estimated completion is 2026-06-27.

What conditions does trial NCT04141878 study?

This clinical trial studies the following conditions: Diabetes, Dementia.

What interventions are being tested in trial NCT04141878?

The interventions under investigation include: Aerobic Exercise (BEHAVIORAL), Diet Skills (BEHAVIORAL).

Who is sponsoring clinical trial NCT04141878?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04141878 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04141878's enrollment target sits among peer trials

400 85th of 338 higher than 250 of 338 other Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04141878, the US trial registry maintained by the National Library of Medicine. NCT04141878 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.